Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 06454467
Shrikant Dnyaneshwar Ankolikar is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at STERLING MULTISPECIALITY HOSPITALS & RES EARCH CENTER LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06454467.Shrikant Dnyaneshwar Ankolikar is currently involved in 3 different roles. Their most recent position is with VINCA CANCER CLINIC PRIVATE LIMITED as a Director. The first company Shrikant Dnyaneshwar Ankolikar was appointed to as a director was STERLING MULTISPECIALITY HOSPITALS & RES EARCH CENTER LLP. Shrikant Dnyaneshwar Ankolikar has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Shrikant Dnyaneshwar Ankolikar is currently associated with 2 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at STERLING MULTISPECIALITY HOSPITALS & RES EARCH CENTER LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06454467.Shrikant Dnyaneshwar Ankolikar is currently involved in 3 different roles. Their most recent position is with VINCA CANCER CLINIC PRIVATE LIMITED as a Director. The first company Shrikant Dnyaneshwar Ankolikar was appointed to as a director was STERLING MULTISPECIALITY HOSPITALS & RES EARCH CENTER LLP. Shrikant Dnyaneshwar Ankolikar has a status of Deactivated. Please verify the details for any specific requirements or conditions.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
2y 7m 1y 4m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| VINCA CANCER CLINIC PRIVATE LIMITED | Director | 21-Nov-2018 |
| VINCA CANCER CLINIC PRIVATE LIMITED | Individual Promoter | 21-Nov-2018 |